rs45499402

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

uric acid measurement

Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele C
OR 0.15
p
N 473,241
Large GWAS
multi-ancestry

serum metabolite level

Allele G
OR 0.23
p 9.0e-13
N 3,926
Large GWAS
Hispanic or Latin American

metabolite measurement

Allele C
OR 0.30
p 2.0e-12
N 4,326
Large GWAS
European

gout

Major TJ et al. A genome-wide association analysis reveals new pathogenic pathways in gout. Nature Genetics 56(11):2392-2406 (2024)
Allele C
OR 1.76
p 4.0e-111
N 241,956
Large GWAS
Hispanic or Latin American

Research that mentions this SNP (1)

Genome‐Wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for Allopurinol
AssociationN=4,446Deanna J. Brackman et al.(2019)· Clinical Pharmacology &amp; Therapeutics

This genome-wide association study of 4,446 allopurinol-treated subjects identified BCRP Q141K (rs2231142) as a significant determinant of poor allopurinol response (P = 8.06 × 10⁻¹¹), with a novel suggestive association in GREM2 (rs1934341, P = 3.22 × 10⁻⁶) for better response. In vitro studies demonstrated that oxypurinol inhibits GLUT9-mediated uric acid uptake (IC₅₀ = 108 µM), suggesting a secondary mechanism of allopurinol action beyond xanthine oxidase inhibition.

Traits studied:Allopurinol responseGoutHyperuricemiaSerum uric acid

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…